A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States
Clinical Transplantation · 2023-07 · 37 (7)
DOI: 10.1111/ctr.14967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 20.03.2023. Verfasst von AnnMarie Liapakis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yale University, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Liver Transplantation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Introduction
A successful living donor liver transplant (LDLT) is the culmination of a multifaceted process coordinated among key stakeholders.
Methods
We conducted an electronic survey of US liver transplant (LT) centers (August 26, 2021–October 10, 2021) regarding attitudes, barriers, and facilitators of LDLT to learn how to expand LDLT safely and effectively in preparation for the American Society of Transplantation Living Donor Liver Transplant Consensus Conference.
Results
Responses were received from staff at 58 programs (40.1% of US LT centers). There is interest in broadening LDLT (100% of LDLT centers, 66.7% of non‐LDLT centers) with high level of agreement that LDLT mitigates donor shortage (93.3% of respondents) and that it should be offered to all suitable candidates (87.5% of respondents), though LDLT was less often endorsed as the best first option (29.5% of respondents). Key barriers at non‐LDLT centers were institutional factors and surgical expertise, whereas those at LDLT centers focused on waitlist candidate and donor factors. Heterogeneity in candidate selection for LDLT, candidate reluctance to pursue LDLT, high donor exclusion rate, and disparities in access were important barriers.
Conclusion
Findings from this study may help guide current and future expansion of LDLT more efficiently in the US. These efforts require clear and cohesive messaging regarding LDLT benefits, engagement of the public community, and dedicated resources to equitably increase LDLT access.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Yale University, New Haven, Connecticut, USA.
- Saint Louis University Center for Abdominal Transplantation, St. Louis, Missouri, USA.
- University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Yale Center for Analytical Sciences, New Haven, Connecticut, USA.
- Ege University School of Medicine, Izmir, Turkey.
ORCID-Profile: Mary Amanda Dew, Michelle T Jesse
Zitieren
APA
Liapakis, A., Agbim, U., Bittermann, T., Dew, M. A., Deng, Y., Gan, G., Emre, S., Hunt, H. F., Olthoff, K. M., Locke, J. E., Jesse, M. T., Kumar, V., Pillai, A., Verna, E., Lentine, K. L., & AST LDLT Consensus Conference Working Group (2023). A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clinical Transplantation, 37(7). https://doi.org/10.1111/ctr.14967
Vancouver
Liapakis A, Agbim U, Bittermann T, Dew MA, Deng Y, Gan G, et al. A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clinical Transplantation. 2023;37(7). doi:10.1111/ctr.14967
BibTeX
@article{Liapakis2023,
author = {Liapakis, AnnMarie and Agbim, Uchenna and Bittermann, Therese and Dew, Mary Amanda and Deng, Yanhong and Gan, Geliang and Emre, Sukru and Hunt, Heather F and Olthoff, Kim M and Locke, Jayme E and Jesse, Michelle T and Kumar, Vineeta and Pillai, Anjana and Verna, Elizabeth and Lentine, Krista L and AST LDLT Consensus Conference Working Group, AST LDLT Consensus Conference Working Group},
title = {A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States},
journal = {Clinical Transplantation},
year = {2023},
volume = {37},
number = {7},
doi = {10.1111/ctr.14967}
}
EUVIMED